COVID-19 Update:

In light of concerns around COVID-19, and the uncertain impact on travel we have decided to postpone the Tanzania meeting to 2022 and organize the 23rd International Conference as a Virtual Meeting. 

The  23rd International Conference on Kaposi’s Sarcoma Herpesvirus (KSHV) and Related Agents Virtual Meeting will take place from June 21 – 24, 2021. On-Demand access to the oral and iPoster sessions will be available following each session, through July 10, 2021 to all registered participants.

Marking the beginning of a new quarter century since the discovery of this cancer virus, KSHV 2021 will be the first in this conference series to be held as a Virtual Meeting. The Virtual Meeting format will allow broader participation and global outreach such that the numerous groundbreaking discoveries can be more quickly disseminated to the researchers and the public health partners working on KSHV and the related agents.

This 23rd iteration of the International KSHV Conference series will continue to serve as the premier forum for the exchange of new developments in the field of the Kaposi’s sarcoma herpesvirus (KSHV), which is the etiological agent of the AIDS defining malignancy, Kaposi’s sarcoma (KS). Researchers in the KSHV field have held 22 previous annual conferences, typically attended by 100-184 participants.

The Organizing Committee is reviewing Virtual Meeting Platforms to find the most suitable technology to provide a lively and fully interactive meeting.

This conference provides a great opportunity for you to participate in the presentations and discussions on scientific advancement in KSHV and related agents, as well as network with other delegates at the conference and during virtual networking events. 

This yearly meeting is key to enhance interactions among scientists in the field and promote interdisciplinary communication and collaborations among researchers with expertise that span molecular virus biology, innate and adaptive immunobiology, animal models of pathogenesis, pathology, epidemiology and therapeutic strategies. Thus, this meeting facilitates cross-fertilization of ideas, techniques, and reagents.

In addition, we believe this venue is a critical environment to strengthen the education and professional development of our trainees, especially African researchers and trainees, spanning graduate students, medical students, post-doctoral fellows and clinical fellows, and pre-tenured early careers faculty. Our meeting encourages the presentation of data before publication to enable open discussion and feedback from a field of experts. There are no invited lectures or keynotes. All contributions are equal, which encourages the participation of trainees.  

This meeting will provide structured networking opportunities for trainees to interact with senior faculty at academic institutions and scientists from industry and government. From bench science to clinical application, a conversation starter for an international collaboration of researchers.

We highly encourage you to prepare and collaborate with colleagues for KSHV 2021 Virtual Meeting!

KSHV 2021 Virtual Meeting Local Organizing Committee:

  • Subhash Verma, University of Nevada, Reno School of Medicine, Reno, USA (Chair)
  • Yoshihiro Izumiya, UC Davis, Sacramento, USA
  • Cyprian C. Rossetto, University of Nevada, Reno, USA
  • Dirk Dittmer, University of North Carolina, Chapel Hill, USA
  • Charles Wood, University of Nebraska, USA